News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medican Announces Final Approval Of Acquisition Terms


5/8/2014 12:41:27 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAS VEGAS--(BUSINESS WIRE)--Medican Enterprises, Inc. (OTCBB:MDCN) a bio-pharmaceutical company focused on developing, and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market is pleased to announce it has received all signatures and approvals necessary for the Amendment Agreement previously announced on May 5, 2014. This agreement sets forth the amended terms for the initial acquisition of 50% of International Herbs Medical Marijuana (IHMML).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES